PAM
SCLN

Princeton Alpha Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Princeton Alpha Management’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-15,018
Closed -$196K – 1048
2016
Q2 		$196K Buy
+15,018
New +$197K 0.03% 676

Other funds holding SCLN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Princeton Alpha Management's SCLN Position: Q3 2016 in Review

Princeton Alpha Management sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q3 2016, closing a stake of 15,018 shares — an estimated $196K sold.

Princeton Alpha Management first reported a position in SCLN in Q2 2016 and held it in 1 quarter. The position peaked at $196K in Q2 2016. 151 funds tracked by Wall St. Rank hold SCLN as of Q3 2016.

  • Princeton Alpha Management reported no remaining Sciclone Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
  • Princeton Alpha Management sold 15,018 Sciclone Pharmaceuticals Inc shares in Q3 2016, an estimated $196K.
  • Princeton Alpha Management first reported a position in Sciclone Pharmaceuticals Inc in Q2 2016 and held it in 1 quarter.
  • Princeton Alpha Management's Sciclone Pharmaceuticals Inc position peaked at $196K in Q2 2016.
  • 151 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q3 2016.

Based on Princeton Alpha Management's 13F filing for Q3 2016, filed 10 Nov 2016.